trending Market Intelligence /marketintelligence/en/news-insights/trending/hx-g-ecrxt_rcp_dwtb75g2 content esgSubNav
In This List

Immune Therapeutics appoints board member

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Immune Therapeutics appoints board member

Immune Therapeutics Inc. appointed Jack Brewer as a board member.

Brewer is the CEO and founder of the Brewer Group Cos. He manages Brewer's private portfolio, which focuses on impact investing.

Immune Therapeutics said that Brewer has assisted in the company's expansion into international markets, such as Malawi and Haiti, and has recently started work to help the company expand registration into India.

Orlando, Fla.-based Immune Therapeutics develops immunotherapies for autoimmune and inflammatory diseases, cancer, HIV/AIDS and animal diseases.